Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cyclamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.91 |
| ▸ | CA7 | P43166 | 3/20 | 0.91 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.91 |
| ▸ | CA9 | Q16790 | 1/20 | 0.91 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclamic Acid SCHEMBL28963281 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL692781 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL1457947 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL414415 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL2188654 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL10856451 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL4592737 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL66221 | 0.95 | CA12 (1.00) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL9591547 | 0.95 | CA12 (0.91) | CA12CA7CA14CA9CA1 | |
| Cyclamic Acid SCHEMBL28154733 | 0.95 | CA12 (1.00) | CA12CA7CA14CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122004086-A | Flower promoting method of golden camellia | 广西壮族自治区南宁良凤江国家森林公园 | 2026-05-12 | — | — | CN | claimed |
| EP-3487318-B1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | PEPSICO INC (US) | 2026-04-01 | — | — | EP | claimed |
| US-20260027150-A1 | SOLID BEVERAGE COMPOSITION AND USE METHOD THEREOF | NANJING NUTRABUILDING BIO TECH CO LTD (CN) | 2026-01-29 | — | — | US | claimed |
| US-12490761-B2 | Liquid concentrate delivery system | FIRMENICH SA (CH) | 2025-12-09 | — | — | US | claimed |
| EP-4642246-A2 | METHODS AND SYSTEMS FOR INDUCING COALESCENCE OF FUNGAL PROTEINS, AND FUNGAL FOOD PRODUCTS MADE THEREBY | The Fynder Group, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| EP-4618781-A1 | CONSUMABLE FOR AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2025-09-24 | — | — | EP | claimed |
| EP-4618780-A1 | CONSUMABLE FOR AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2025-09-24 | — | — | EP | claimed |
| US-20250089750-A1 | SWEETENED COMPOSITION | FIRMENICH SA (CH) | 2025-03-20 | — | — | US | claimed |
| EP-3866762-B1 | GALACTOSE ORAL COMPOSITION AND USE THEREOF | AVALON HEPAPOC LTD (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-118787123-A | Water-based electronic cigarette atomization preparation and preparation method and application thereof | 思摩尔国际控股有限公司 | 2024-10-18 | — | — | CN | claimed |
| WO-2023020949-A1 | SWEETENED COMPOSITION | FIRMENICH SA (CH) | 2023-02-23 | — | — | WO | claimed |
| US-11540542-B2 | Taste modulating aldehydes | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-01-03 | — | — | US | claimed |
| CN-109996778-B | Taste modifying aldehydes | 高砂香料工业株式会社 | 2022-12-13 | — | — | CN | claimed |
| US-11479722-B2 | Method for preparing dispersant using lignin degradation products | FU ZHOU UNIVERSITY (CN) | 2022-10-25 | — | — | US | claimed |
| CN-108864870-B | Preparation method of alkali-resistant water-based metal exterior wall coating | 枞阳县三金颜料有限责任公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114456420-A | Environment-friendly degradable food-grade antibacterial plastic packaging film and preparation method thereof | 北京工商大学 | 2022-05-10 | — | — | CN | claimed |
| US-20220110353-A1 | LIQUID CONCENTRATE DELIVERY SYSTEM | FIRMENICH & CIE (CH) | 2022-04-14 | — | — | US | claimed |
| CN-109320283-B | Fly ash autoclaved aerated concrete block | 襄阳华壁新型建材有限公司 | 2021-09-17 | — | — | CN | claimed |
| US-7744815-B2 | Apparatus comprising cyclohexylsulfamic acid and/or salts for use in detection and quantification of chlorine dioxide in foreign gas | Dräger Safety AG & Co., KGaA (DE) | 2010-06-29 | — | — | US | claimed |
| US-20080076185-A1 | DEVICE FOR DETERMINING CHLORINE DIOXIDE AND METHOD | DRAGER SAFETY AG & CO. KGAA (DE) | 2008-03-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11540542-B2 | Taste modulating aldehydes | TAS2R10, TAS2R50, TAS2R1 | CA12 1081/4885CA7 1892/4885CA14 912/4885 |
| US-20260027150-A1 | SOLID BEVERAGE COMPOSITION AND USE METHOD THEREOF | SLC5A6, SORD, UGCG | CA12 96/4885CA7 98/4885CA14 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.